• SK Capital to buy API business from Perrigo Company pharmaceutical-technology
    August 15, 2017
    Private investment company SK Capital has signed a new definitive agreement to purchase Perrigo Company’s active pharmaceutical ingredients (API) business, Perrigo API.Perrigo API develops and produces generic APIs and finished dose forms (FDF).
PharmaSources Customer Service